Stock Taper Revenue: $756 million, up 18% year-over-year, exceeding guidance.
Non-GAAP EPS: $0.75, up 36% year-over-year, also above guidance.
Non-GAAP Gross Margin: 10.5%, improved by 30 basis points year-over-year.
Non-GAAP Operating Margin: 5.2%, up 50 basis points year-over-year.
Operating Cash Flow: $35 million; Free Cash Flow: $22 million.
Cash Position: $315 million in cash, $134 million net of debt.
Capital Expenditures: Approximately $13 million, with expectations to maintain 2% to 2.5% of revenue for the full year.
Sector Performance:
Strong growth in Semi-Cap (17%), Industrial (13%), Medical (22%), and AC&C (71%).
Aerospace & Defense (A&D) revenue declined 12% year-over-year due to program transitions.
New Facilities:
Fourth PT facility in Penang ramping operations; new facility in Thailand to break ground in Q3 2026.
Operational Efficiency: Improved cash conversion cycle to 59 days, down 26 days year-over-year.
2026 Revenue Outlook: Increased to $3 billion, representing approximately 13% growth.
Q3 2026 Guidance: Revenue expected between $755 million and $795 million, with non-GAAP EPS between $0.76 and $0.82.
Sector Expectations: Continued growth anticipated in Semi-Cap and Medical, while A&D expected to stabilize in the second half of 2026.
A&D Sector Decline: A&D revenue down due to program timing; expected to stabilize but not grow until 2027.
Supply Chain Issues: Ongoing tightness in supply chain, particularly for complex components, with lead times extending significantly for some parts.
Variable Compensation Impact: Increased variable compensation expenses affected operating margins.
A&D Bookings: CEO David Moezidis highlighted strong new bookings in defense and space sectors, indicating optimism despite current revenue declines.
Competitive Takeaways: Success in gaining market share in the Industrial sector attributed to operational execution and creative solutions.
Medical Sector Recovery: Growth driven by increased demand and successful competitive takeaways, with expectations for continued improvement.
Future CapEx: Continued investment in growth initiatives expected to align with revenue growth, maintaining a disciplined capital allocation strategy. Overall, Benchmark Electronics reported a strong quarter with significant revenue growth and operational improvements, while navigating challenges in the A&D sector and supply chain. The company remains optimistic about future growth across most sectors, particularly Semi-Cap and Medical.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT